(Q30395810)

English

Nasal vaccine innovation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 June 2017

Nasal vaccine innovation (English)

1 reference

Europe PubMed Central

21 June 2017

author name string

Inderjit Jabbal-Gill

1

1 reference

Europe PubMed Central

21 June 2017

publication date

1 December 2010

1 reference

Europe PubMed Central

21 June 2017

Journal of Drug Targeting

1 reference

Europe PubMed Central

21 June 2017

18

1 reference

Europe PubMed Central

21 June 2017

10

1 reference

Europe PubMed Central

21 June 2017

771-786

1 reference

Europe PubMed Central

21 June 2017

Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Chitosan-based delivery systems for protein therapeutics and antigens

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Chitosan-based systems for the delivery of vaccine antigens

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Role of influenza vaccine for healthy children in the US.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Lipid based particulate formulations for the delivery of antigen.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Applications of influenza virosomes as a delivery system.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Virosomes for antigen and DNA delivery

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Effect of chitosan on epithelial permeability and structure.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Comparison of the mucoadhesive properties of various polymers.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Effect of Viscosity on Particle Size, Deposition, and Clearance of Nasal Delivery Systems Containing Desmopressin

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Immunostimulating complexes (ISCOMs) for nasal vaccination

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

The virosome concept for influenza vaccines

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Chitosan as a novel nasal delivery system for vaccines

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Polymeric lamellar substrate particles for intranasal vaccination

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Nanoparticles as carriers for nasal vaccine delivery.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

ISCOM based vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Induction, function and regulation of IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Adjuvant synergy: the effects of nasal coadministration of adjuvants.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Epithelial M cells: gateways for mucosal infection and immunization

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Recent advances in the discovery and delivery of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Modeling chromatographic columns non-equilibrium packed-bed adsorption with non-linear adsorption isotherms.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Race for pandemic flu vaccine rife with hurdles

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

The basics and underlying mechanisms of mucoadhesion

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Potential applications of chitosan in veterinary medicine

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Advances in saponin-based adjuvants

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Adjuvant activity of cytokines

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Adverse events associated with intranasal influenza vaccine in the United States

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Synthetic biomimetic supra molecular Biovector (SMBV) particles for nasal vaccine delivery

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Predictions for future human influenza pandemics

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

New loading process and release properties of insulin from polysaccharide microcapsules fabricated through layer-by-layer assembly

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Efficient delivery of DNA to dendritic cells mediated by influenza virosomes

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

21 January 2018

Identifiers

10.3109/1061186X.2010.523790

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30395810&oldid=1549839335"